2023
DOI: 10.1093/neuonc/noad073.242
|View full text |Cite
|
Sign up to set email alerts
|

MDB-09. Impact of Prdm6 on Chromatin Accessibility, Gene Expression, and Medulloblastoma Formation

Abstract: Group 4 medulloblastoma (MB) is the most common medulloblastoma subgroup and shows high incidence of metastasis and late-onset relapse cases. These tumors lack a unifying oncogenic driver and treatment targets, despite extensive genomic characterization. Group 4 MBs are characterized by recurrent genetic alterations in chromatin modifiers and amplification of stemness genes. A substantial fraction of Group 4 MBs are characterized by enhancer hijacking through tandem duplication of SNCAIP, resulting in high exp… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles